Implanting the enVista IOL

Show Description +

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Implanting the enVista IOL

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Please log in to leave a comment.

More in Cataract

Phacoemulsification With Real-Time Remote Collaboration

Ernesto Calvo, MD; Salomon Abouganem, MD; and Eric Rosenberg, DO

Case-Based Confidence With LenSx® OnAxis

Zarmeena Vendal, MD; Scott LaBorwit, MD; and Heather Weissman, MD

OnAxis Workflow Confidence From Clinic to OR

Zarmeena Vendal, MD; Scott LaBorwit, MD; and Heather Weissman, MD

LenSx® Momentum and the Platform That Keeps Evolving

Zarmeena Vendal, MD; Scott LaBorwit, MD; and Heather Weissman, MD